🇺🇸 FDA
Pipeline program

HH-003(20mg/kg)

HH003-204

Phase 2 mab completed

Quick answer

HH-003(20mg/kg) for Chronic Hepatitis Delta Virus Infection is a Phase 2 program (mab) at Huahui Health with 1 ClinicalTrials.gov record(s).

Program details

Company
Huahui Health
Indication
Chronic Hepatitis Delta Virus Infection
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials